Back
Pacira BioSciences Stock Price Chart

FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here
Sell
27
PCRX
Pacira BioSciences
Last Price:
$24.46
Seasonality Move:
0.52%
7 Day Trial
ALL ACCESS PASS
$
7

Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PCRX is experiencing slight buying pressure.
Pacira BioSciences Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.89 | Sell |
20-day SMA: | 25.54 | Sell |
50-day SMA: | 24.67 | Sell |
200-day SMA: | 20.13 | Buy |
8-day EMA: | 24.85 | Sell |
20-day EMA: | 25.19 | Sell |
50-day EMA: | 24.8 | Sell |
200-day EMA: | 23.18 | Buy |
Pacira BioSciences Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 45.4 | Sell |
Chaikin Money Flow: | 424208 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.43 - 26.35) | Sell |
Bollinger Bands (100): | (21.32 - 26.32) | Buy |
Pacira BioSciences Technical Analysis
May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Pacira BioSciences Stock
Is Pacira BioSciences Stock a Buy?
-
Pacira BioSciences share price is 24.45 while PCRX 8-day simple moving average is 24.89, which is a Sell signal.
-
The stock price of PCRX is 24.45 while Pacira BioSciences 20-day SMA is 25.54, which makes it a Sell.
-
Pacira BioSciences 50-day simple moving average is 24.67 while PCRX share price is 24.45, making it a Sell technically.
-
PCRX stock price is 24.45 and Pacira BioSciences 200-day simple moving average is 20.13, creating a Buy signal.
PCRX Technical Analysis vs Fundamental Analysis
Sell
27
Pacira BioSciences (PCRX)
is a Sell
Is Pacira BioSciences a Buy or a Sell?
-
Pacira BioSciences stock is rated a SellThe current Pacira BioSciences [PCRX] share price is $24.45. The Score for PCRX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Pacira BioSciences Stock Info
Market Cap:
1.1B
Price in USD:
24.45
Share Volume:
1.1M
Pacira BioSciences 52-Week Range
52-Week High:
31.67
52-Week Low:
11.16
Sell
27
Pacira BioSciences (PCRX)
is a Sell
Pacira BioSciences Share Price Forecast
-
What is the Pacira BioSciences stock price today?The Pacira BioSciences stock price is 24.45 USD today.
-
Will PCRX stock go up or go down?Pacira BioSciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Pacira BioSciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pacira BioSciences is overvalued.
Is Pacira BioSciences Stock a Buy?
-
Pacira BioSciences share price is 24.45 while PCRX 8-day exponential moving average is 24.85, which is a Sell signal.
-
The stock price of PCRX is 24.45 while Pacira BioSciences 20-day EMA is 25.19, which makes it a Sell.
-
Pacira BioSciences 50-day exponential moving average is 24.80 while PCRX share price is 24.45, making it a Sell technically.
-
PCRX stock price is 24.45 and Pacira BioSciences 200-day simple moving average is 23.18, creating a Buy signal.
Fundamental Analysis of Pacira BioSciences
Is Pacira BioSciences a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.16 per share, a decrease this year of $0.35 per share, and an increase next year of $0.66 per share.
Technical Analysis of Pacira BioSciences
Should I short Pacira BioSciences stock?
-
PCRX Moving Average Covergence Divergence (MACD) indicator is -0.09, suggesting Pacira BioSciences is a Sell
-
Pacira BioSciences Relative Strength Index (RSI) is 45.4, which suggest Pacira BioSciences is oversold
-
The Bollinger Bands (25) for Pacira BioSciences is (24.43 - 26.35), which suggest Pacira BioSciences is a Buy
-
The Bollinger Bands (100) for Pacira BioSciences is (21.32 - 26.32), which suggest Pacira BioSciences is a Buy
* Pacira BioSciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.